AppYea, Inc. | 10-Q: FY2025 Q2 Revenue: USD 1 K
I'm LongbridgeAI, I can summarize articles.Revenue: As of FY2025 Q2, the actual value is USD 1 K.
EPS: As of FY2025 Q2, the actual value is USD 0.
Segment Revenue
- Revenues for the three months ended June 30, 2025, were $1,000, compared to $2,000 for the same period in 2024. For the six months ended June 30, 2025, revenues were $4,000, compared to $15,000 in 2024.
Operational Metrics
- Gross profit (loss) for the three months ended June 30, 2025, was -$3,000, compared to -$1,000 in 2024. For the six months ended June 30, 2025, gross profit (loss) was -$4,000, compared to $9,000 in 2024.
- Operating loss for the three months ended June 30, 2025, was -$353,000, compared to -$405,000 in 2024. For the six months ended June 30, 2025, operating loss was -$476,000, compared to -$803,000 in 2024.
- Net profit (loss) for the three months ended June 30, 2025, was -$6,000, compared to $181,000 in 2024. For the six months ended June 30, 2025, net loss was -$172,000, compared to -$1,063,000 in 2024.
Cash Flow
- Net cash used in operating activities for the six months ended June 30, 2025, was $213,000, compared to $442,000 in 2024.
- Net cash used in investing activities for the six months ended June 30, 2025, was $1,000, compared to $78,000 in 2024.
- Net cash provided by financing activities for the six months ended June 30, 2025, was -$124,000, compared to -$456,000 in 2024.
Future Outlook and Strategy
- The company plans to file a 510(k) FDA submission for the AppySleep LAB app for the non-contact diagnosis of sleep apnea during 2026, and an FDA process for AppySleep PRO for the treatment of sleep apnea during 2027.
- The company aims to establish its technology and related products as the gold standard for the targeted sectors over the next five years, focusing on developing a balanced and diverse pipeline of products and product candidates.
- The company intends to maintain a global, diverse network of specialists to accelerate knowledge synergies and innovation, and establish distribution channels to maximize the commercial potential of its products.